Condition
Sinonasal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Sinonasal Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in China (4), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Sinonasal Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma | — | Harbin, Heilongjiang and 5 other locations | Recruiting | Jun 17, 2026 |
| Surgery Alone or with Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma | — | Shanghai | Recruiting | May 1, 2026 |
| Becotatug vedotin plus epirubicin before surgery for EGFR-positive unresectable recurrent sinonasal adenoid cystic carcinoma | Phase 2 | Shanghai | Recruiting | Apr 13, 2026 |
| Epirubicin chemoembolization to shrink sinonasal adenoid cystic carcinoma | Phase 2 | Shanghai, Xuhui Strict | Recruiting | Jan 6, 2026 |
| Study of sinonasal cancer outcomes and quality of life | — | Rochester, Minnesota | Recruiting | Feb 16, 2021 |
All recruiting trials (5)
-
Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma
This study tests how well patients with T4 sinonasal adenoid cystic carcinoma tolerate the standard treatment of surgery followed by postoperative radiotherapy and what their 3-year progression-free survival looks like.
-
Surgery Alone or with Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma
This study tests whether watching closely after surgery is as safe as adding postoperative radiotherapy for adults with completely removed (R0) early-stage sinonasal adenoid cystic carcinoma.
-
Becotatug vedotin plus epirubicin before surgery for EGFR-positive unresectable recurrent sinonasal adenoid cystic carcinoma
This will test whether combining becotatug vedotin with epirubicin can shrink EGFR-positive, unresectable recurrent sinonasal adenoid cystic carcinoma enough to allow surgery or improve disease control.
-
Epirubicin chemoembolization to shrink sinonasal adenoid cystic carcinoma
This treatment tries three sessions of targeted transarterial Epirubicin chemoembolization in people with locally advanced sinonasal adenoid cystic carcinoma to shrink tumors and decide if surgery can be avoided.
-
Study of sinonasal cancer outcomes and quality of life
This study looks at how sinonasal cancer affects patients' lives and treatment results to help improve future care for those diagnosed with this type of cancer.
Related topics
Quick answers
How many Sinonasal Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.